{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-21-003064","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2021-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.358838+00:00","generated_at":"2026-06-28T03:10:53.072146+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Artelo Biosciences grants CEO Gregory Gorgas option for 1.355M shares at $0.63","bullets":["Option to purchase 1,355,000 shares of common stock at exercise price of $0.63 per share.","Granted on December 3, 2021 under the 2018 Equity Incentive Plan.","Vesting: 25% on December 3, 2022; remaining shares vest ratably monthly over 36 months.","Continued service as a Service Provider required for vesting."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-21-003064","json":"https://secwatch.observer/filing/0001640334-21-003064.json","markdown":"https://secwatch.observer/filing/0001640334-21-003064.md","text":"https://secwatch.observer/filing/0001640334-21-003064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033421003064/0001640334-21-003064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033421003064/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T03:10:53.072146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}